El teléfono móvil no es solo un dispositivo; es el epicentro de la vida moderna. Sin embargo, antes de que los smartphones dominaran nuestra atención, hubo una carrera tecnológica marcada por la audacia de ingenieros que desafiaron las limitaciones del cableado fís …
Grandes inventos de la humanidad: El teléfono móvil Read More »
Si eres un apasionado de la ciencia ficción de “guante blanco” —aquella que no solo te hace soñar, sino que te obliga a pensar y a cuestionar las leyes de la física—, “Horizontes del Futuro” de Víctor Arenas no es solo una recomendaci&oacut …
Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit while applying deeper, domain-specific diligence to early stage bets.
Biotech angels lean into deeper diligence and disciplined early bets Read More »
No es solo una molestia o una falta de sueño reparador. La ciencia más reciente confirma que la contaminación acústica durante la noche actúa como un estresor fisiológico capaz de desencadenar eventos cardiovasculares fatales. La dictadura del decib …
Por qué el ruido nocturno está acortando nuestra vida Read More »
Staff at Salt Lake City-based techbio company Recursion recently heard from Jenny and Tim Jones about their challenging family history of familial adenomatous polyposis.
Patient advocate offers Recursion a powerful reason to keep going in rare disease Read More »
With six acquisitions already this year, Eli Lilly’s business development shows no signs of stopping as executives make good on a promise to spend their GLP-1 gains.
Lilly can’t stop the dealing, with nearly $21B spent on M&A this year—so far Read More »
Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.
Altitude Labs serves up higher education for biotech founders Read More »
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
J&J starts head-to-head PFA trial against Boston Scientific device Read More »
The insurer, a mainstay in government programs like Medicaid and the ACA exchanges that have been wracked by higher spending, successfully controlled costs in the quarter, leading to $1.5 billion in profit.
Centene hikes 2026 profit guidance after buoyant Q1 Read More »
The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.
Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg Read More »
